ARTICLE | Distillery Therapeutics
SMPDL3b inhibition or C1P supplementation for diabetic kidney disease
July 11, 2019 10:13 PM UTC
INDICATION: Diabetic nephropathy ...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
INDICATION: Diabetic nephropathy ...
BCIQ Company Profiles